Oramed Pharmaceuticals entered into a Securities Purchase Agreement with Scilex, receiving a $101.9 million promissory note and warrants, and later refinanced part of this note, reducing its principal by $22.5 million, with $80.2 million repaid or re
AI Assistant
ORAMED PHARMACEUTICALS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.